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Abstract 
Background and aims. The purpose of our study was to determine the features of diabetic 
nephropathy, to identify the relationship between the level of albumin excretion, urine  and 
lipid profile, genotype variants of the CYP7A1 gene in people with type 2 diabetes and 
diabetic nephropathy. Material and methods. Patients were divided into three groups. 
Normoalbinuria was detected in group I, and II - microalbuminuria, and III - 
macroalbuminuria. Determination of albumin to creatinine ratio was more accurate, 
although more expensive method. We examined single nucleotide polymorphism -204A> C 
[rs 3808607] of the promoter region of the CYP7A1 gene. Results. It was established that 
homozygotes by the major allele with genotype AA had lower values of albuminuria, 
atherogenic lipoproteins, total cholesterol, triglycerides and higher levels of anti- 
atherogenic lipoproteins than patients with AС and СС genotypes. Conclusion. The СС 
genotype was most unfavorable in the prognostic plan, since homozygotes for this minor 
allele were characterized by higher values of albuminuria, total cholesterol, triglycerides, 
and lower values of high-density lipoprotein 
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[4], which is also considered a risk factor for the 
Background and aims 
Today, diabetes mellitus (DM) plays a 
significant role in the development of 
nephropathy and the formation of chronic kidney 
disease (CKD) [1]. Approximately 30% of 
patients with diabetes confirmed nephropathy 
[2,3]. 
The earliest indicator of the development of 
diabetic nephropathy (DN) is microalbuminuria 
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development of cardiovascular complications [5-
7]. 
DM is a specific defeat of the kidneys with 
diabetes, which is characterized by glomerular 
sclerosis and interstitial, which leads to a gradual 
loss of renal function. 
Hyperglycemia is a major metabolic initiator 
of development of diabetic kidney damage. 
Mechanisms of nephrotoxic action of 
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hyperglycemia include non-enzymatic 
glycosylation of proteins of renal membranes, as 
a result their structure and function is changes; 
direct toxic effect of glucose on the renal tissue, 
which leads to activation of the protein kinase C 
enzyme and increased renal vascular 
permeability; the activation of peroxidation of 
lipids, resulting in the formation of a large number 
of free radicals of cytotoxic action [8]. Direct 
damage to the endothelium of the vessels results 
in an increase in the glomerular barrier 
permeability for a fine-dispersed, highly 
selective, albumin-protein fraction. Since the 
kidneys are the organ with the highest 
concentration of arterioles in the body, the 
systemic defeat of the endothelium is manifested 
by a phenomenon of albuminuria. 
Hyperlipidemia is another metabolic 
progression factor of DN. Oxidized low density 
lipoproteins penetrate the damaged endothelium 
of the capillaries of the renal glomeruli, admiring 
the mesangial cells with the formation of foamy 
cells around which collagen fibers are formed, 
and glomerulosclerosis develops [9,10]. 
Determining of albumin to creatinine ratio in 
urine is a more accurate method than the 
definition of albuminuria, since the level of 
creatinine excreted in urine depends on age, sex, 
body mass index [11]. 
Glucose can interact with a variety of proteins 
and form additional glycogen compounds that 
contribute to endothelial dysfunction, the 
development of the atherosclerotic process, 
vascular thrombosis [12-14]. One of them is 
glycosylated hemoglobin (HbA1c), which is 
accumulated inside the erythrocytes and is 
maintained throughout its entire functioning. 
Since the half-cycle of erythrocyte circulation in 
the bloodstream is 60 days, the concentration of 
HbA1c reflects the patient's glycemia in 60-90 
days prior to the study [15]. Considering the life 
expectancy of erythrocyte, which is 120 days, it is 
expedient to determine the level of HbA1c once 
every three or four months [2,3]. 
Releasing chemotactic cytokines and 
adhesion molecules on its inner surface promotes 
the adhesion of circulating mononuclear cells to 
the vascular wall. Inflammatory mediators 
activate smooth muscle cells, causing their 
proliferation and migration under the intima of 
blood vessels. 
It is in the presence of dyslipidemia that 
monocytes, which are contained in the vascular 
wall, react with cholesterol of low-density 
lipoprotein (LDL) and turn into macrophages 
containing lipids, which is the basis of the 
atherosclerotic process. Macrophages decree 
metal proteases and cathepsins by destabilizing 
the fibrous capsule of the atherosclerotic plaque, 
which can lead to rupture of the atherosclerotic 
plaque and release of the tissue factor that causes 
thrombosis, occlusion of coronary vessels, and 
acute myocardial infarction [16,17]. 
Insulin activates the synthesis of free fatty 
acids (FA) and triglycerides (TG), reduces the 
rate of ß-oxidation of FA in the liver, which leads 
to deposition in the liver TG. This leads to the 
development of insulin resistance (IR) and 
subsequent deposition of fat in the liver. Glucose 
metabolism may be associated with bile acid 
metabolism [18]. Cholesterol 7-alpha- 
hydroxylase (CYP7A1) is the first enzyme in a 
series of cholesterol transformations, which 
results in the synthesis of bile acids [19]. 
CYP7A1 belongs to a large family of 
cytochromes p450. The gene encoding the 
CYP7A1 enzyme is located on the 8q11-12 
chromosome and consists of 6 exons and 5 
introns. Genetic variants of this gene have an 
effect on levels of LDL and TG [20]. The 
polymorphism -204A> C [rs 3808607] of the 
gene CYP7A1 is located on the promoter region 
[21,22]. A correlation was found between the 
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lipid profile of the blood and the given 
polymorphism [20,23]. 
The purpose of the study was the 
determination of the indices of blood lipid profile, 
single nucleotide polymorphism-204A> C [rs 
3808607] of the CYP7A1 gene, depending on the 
level of albuminuria in individuals with type 2 
diabetes and diabetic nephropathy. 
 
Materials and methods 
Sixty patients with type 2 diabetes and 
diabetic nephropathy were examined. The 
diagnosis of diabetes was established if the blood 
glucose content in the onset of blood was greater 
than 6.1 mmol / l, with a pre-starvation of 12 
hours and more than 11.1 mmol / L two hours 
after loading with glucose (75 g). The analysis 
was repeated 2-3 times on other days. Diabetic 
nephropathy has been established if the GFR> 90 
ml / min. 
The patients were divided into groups 
depending on the level of albumin excreted in the 
urine, determined in a one-time morning portion 
of the urine. The determination of albuminuria 
was carried out by the immunoassay method on a 
semi-automatic analyzer BA-88 (China). 
In patients of the first (I) group, 
normalbumbumurium was detected, at the level 
of secreted protein <20 mg / l, the second - 
microalbuminuria (20-200 mg / l), and the third - 
macroalbuminuria (> 200 mg / l). 
The mean age of patients in the I group was 
(55.44 ± 0.23) years, II - (64.92 ± 0.31) years, t 
= 24.56; p <0.001, ІІІ - (60.37 ± 0.28) years, t = 
13.6; p<0.001. 
The level of HbA1c in serum was determined 
by high-sensitivity ion-exchange chromatography 
using the automatic analyzer D10 and BIO-RAD 
(USA) reagents. 
In all patients, the single-nucleotide 
polymorphism -204A> C [rs 3808607] of the 
promoter region of the gene CYP7A1 expressing 
the enzyme cholesterol 7α-hydroxylase has been 
studied. We identified three genotypes: AA, AC, 
CC. The lipid blood spectrum for each of the 
genotypes was investigated. 
The determination of the mononucleotide 
polymorphism -204A>C [rs 3808607] of the 
CYP7A1 gene was carried out using a polymerase 
chain reaction method followed by an analysis of 
the length of the restriction fragments. 
All patients were tested for lipid profile and 
an index of atherogenicity was calculated. 
Biochemical analysis of blood was determined 
such indicators of the lipid spectrum of blood as 
total cholesterol (TC), TG and high density 
lipoprotein (HDL), LDL, and very low density 
lipoprotein (VLDL). 
LDL cholesterol was calculated by the 
formula: 
 
LDL = TC – (HDL + TG/2,2) 
 
If the TG content exceeded 4.5 mmol / L, then 
LDL cholesterol was calculated using the 
Friedwald formula: 
 
LDL = TC – HDL – 0,45×TG 
 
LPDL = TG: 2,18. 
The index of atherogenicity was also 
calculated. The coefficient of atherogenicity (CA) 
is calculated very simply: CA = (total cholesterol 
- HDL) / HDL. 
The obtained results were processed by the 
method of variation statistics using the programs 
Microsoft Exel 2007 and statistics for Windows 
6.0 using Student's criterion. The average 
arithmetic mean value (M), the mean arithmetic 
mean error (m) was calculated. 
 
Results 
After determining the amount of urine- 
excreted protein, it was found that 44 patients 
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(73.33%) had normoalbuminuria, 8 (13.33%) – 
microalbuminuria, and 8 (13.33%) – macro- 
albuminuria. Proteinuria was not diagnosed in 
any patient. Since the amount of creatinine 
excreted in urine may be different and depend on 
body weight, age of patients, we decided to 
determine the ratio of microalbumin to creatinine 
in urine, after which normoalbuminuria was 
detected        in        41        patients      (68.33%), 
microalbuminuria at 9 (15.0%), 
macroalbuminuria - in 9 (15.0%) proteinuria - in 
1 (1.66%). Possibly, in the past, the value of the 
protein isolated from the urine was greater but 
decreased in the result of the nephroprotective 
effect of antihypertensive drugs that patients had 
taken over the years. 
In 57 patients (95.0%), the level of protein 
isolated from urine, determined after the 
determination of albuminuria and the ratio of 
albumin to creatinine, coincided, and in 3 (5.0%) 
was different. 
Thus, a more accurate method with a 
difference of 5.0% for the study of kidney 
function in type 2 diabetes is to determine the 
ratio of albumin to creatinine. 
Duration of diabetes in people with 
normoalbuminuria was (5.43 ± 0.05) years, with 
microalbuminuria   -   (10.22   ±   0.22)   years,   t 
= 21,23; p <0.001, with macroalbuminuria - (14.3 
± 0.37 years) years, t = 23.78; p < 0.001. It has 
been shown that the duration of the disease on 
type 2 diabetes correlates with the level of 
albuminuria. 
For individuals of group І, the level of HbA1c 
was (6.21 ± 0.23)%, for ІІ - (7.31 ± 0.22)%, t = 
3.46; p <0.01, for ІІІ - (7.65 ± 
0.45)%, t = 2.85; p <0.01 Consequently, a direct 
proportional relationship was found between the 
degree of albuminuria and the level of HbA1c. 
After determining the lipid profile of the 
blood, a direct proportional relationship was 
found between the degree of albuminuria and the 
level of Total Cholesterol (TC), TG, LDL, LDL, 
and inversely proportional dependence on HDL. 
 
 
TC LDL VLDL TG HDL 
 
Fig. 1. Dynamics of lipid profile of blood depending on the level of albuminuria in patients with type 2 diabetes. 
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Fig. 2. Frequency of allelic variants of the gene of CYP7A1 for polymorphism -204A> C. 
 
In the 1st, 2nd, 3rd group, the level of TC 
was (4,4 ± 0,04) mmol / l, (4,8 ± 0,06) mmol / l, 
t  =  6,57,  p  <0,001,  (5,6 ±  0.23)  mmol /  l, t = 
3.36, p <0.01, LDL - (2.53 ± 0.5) mmol / l, (3.08 
± 0.05) mmol / l, t = 4.7, p < 0.001, (3.96 ± 
0.35),  t  = 2.34,  p < 0.05;  LPDL  - (0.78 ± 0.05) 
mmol / L, (0.84 ± 0.02) mmol / L, t = 4.9, p 
<0.001, (0.9 ± 0.01) mmol / L , t = 2.35, p <0.05, 
HDL - (1.1 ± 0.04) mmol / l, (0.9 ± 0.01) mmol / 
l, t = 4.85, p <0.001 (0.76 ± 0.03) mmol / l, t = 
6.8, p <0.001, TG - (1.7 ± 0.04) mmol / L, (1.83 
± 0.01) mmol / L, t = 3.15, p <0.01, (1.96 ± 0.05) 
mmol / l, t = 4.06, p <0.001 (Figure 1). 
In persons with type 2 diabetes and AG of the 
third stage, 43 (71.66%) persons of the AA 
genotype met, in the AC - 4 (6.66%), CC - in 13 
(21.66%) persons. Consequently, the major allele 
should be considered allele A, and minor - allele 
C. In addition, among 44 patients with 
normoalbuminuria, the genotype AA was 
confirmed in 43 (97.73%), in the AC - in 1 
(2.27%). In people with microalbuminuria, the 
genotype of the AC was detected in 3 (37.5%), 
CC - in 5 (62.5%) patients. All of the subjects who 
had macroalbuminuria determined the CC 
genotype (Figure 2). 
 
 
 
 
Fig. 3. The level of TC with different genotypes of CYP7A1. 
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Fig. 4. The level of LDL in different genotypes is CYP7A1 
 
Fig. 5. VLDL level at different genotypes of CYP7A1 
 
 
Fig. 6. TG level with different genotypes of CYP7A1 
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Fig. 7. The level of high-density lipoprotein with different genotypes of CYP7A1 
 
Specific features of the blood lipid profile 
were also determined, depending on the 
genotypes AA, AC and CC. 
It was found that in homozygotes with AA- 
genotype the levels of LDL, LDL, TG, TC were 
lower and HDL – higher. In the heterozygotes 
with the AC-genotype, the values of atherogenic 
lipoproteins, TG, and TC were higher, and the 
lower ones were antiatherogenic compared with 
those who had the AA-genotype. In the 
homozygote for the minor allele (CC-genotype), 
the values of LDL, VLDL, TG, and TC were the 
largest, and HDL were the smallest. 
 
Conclusions 
Determination of the ratio of albumin to 
creatinine in a one-morning portion of urine is 
more accurate, more expensive marker of DN 
than the counting of only albuminuria. 
There is a direct proportional relationship 
between the level of HbA1c and the duration of 
type 2 diabetes, diabetic nephropathy. 
The degree of albuminuria is positively 
correlated with the level of LDL, VLDL, TG, TC. 
CC-genotype-204A> C [rs 3808607] of the 
promoter region of the CYP7A1 gene is the most 
adverse in the prognostic plan and is associated 
with a higher level of albuminuria, HbA1c, 
atherogenic lipoproteins, and lower anti- 
atherogenic lipoproteins. 
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